Leading and Exporters of Acalamed Acalabrutinib 100mg Capsules, Acaone Acalabrutinib 100mg Capsules, Azacitidine 100mg Injection, Azatend-O Azacitidine 200mg Tablets, Bortesam Bortezomib 2mg Injection, Bortimak Bortezomib 2mg Injection, Borzomed Bortezomib 2mg Injection, Borzomed Bortezomib 3.5mg Lyophilized Injection, Cytaron Cytarabine 100mg Injection, Eltrombopag Olamine 50mg Tablets, Eltropag Eltrombopag 50mg Tablets, Hematoplate Eltrombopag 50mg Film Coated Tablets, Ibruon Ibrutinib 140mg Capsules, Ibrutinib 140mg Hematology Treatment Capsules, Makbine Cytarabine 100mg Injection, Makmustine Bendamustine 100mg Injection, Rompag Eltrombopag 50mg Tablets and Valentax Venetoclax 100mg Tablets from Mumbai.
| Business Type | Manufacturer, Exporter, Supplier |
| Manufacturer | Medicamen Biotech Ltd. |
| Packaging Size | 30 Capsules |
| Brand | Acalamed 100mg |
| Active Ingredient | Acalabrutinib |
| Storage | Store Below 30°C |
| Packaging | Bottle |
| Composition | Acalabrutinib 100mg |
| Form | Solid Capsule |
| Strength | 100mg |
| Prescription | Hematologist/Oncologist Prescription Only |
| Dosage Form | Hard Gelatin Capsule |
| Product Name | Acalamed Acalabrutinib 100mg Capsules |
| Therapeutic Class | Antineoplastic |
| Drug Class | Bruton’s Tyrosine Kinase Inhibitor |
| Route | Oral |
| Indications | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma,Mantle Cell Lymphoma |
| Administration | Oral Use Only |
| Marketer | Medicamen Biotech Ltd. |
| Business Type | Manufacturer, Exporter, Supplier |
| Brand | AcaOne |
| Dosage Form | Hard Gelatin Capsules |
| Packaging Size | 30 Capsules |
| Active Ingredient | Acalabrutinib 100mg Equivalent |
| Storage | Below 30°C |
| Packaging | Bottle |
| Composition | Acalabrutinib |
| Manufacturer | MSN Laboratories Private Limited |
| Strength | 100mg |
| Route Of Administration | Oral |
| Therapeutic Class | Antineoplastic |
| Drug Class | Bruton’s Tyrosine Kinase (BTK) Inhibitor |
| Indications | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma & Mantle Cell Lymphoma |
| Capsule Shell | Titanium Dioxide, FD&C Blue & Ferric Oxide Yellow |
| Prescription Status | Prescription Medicine |
| Pack Quantity | 30 Capsules |
| Business Type | Manufacturer, Exporter, Supplier |
| Brand | Azaciton |
| Product Type | Cytotoxic Agent |
| Generic Name | Azacitidine For Injection IP |
| Active Ingredient | Azacitidine |
| Strength | 100 Mg |
| Dosage Form | Lyophilized Powder For Injection |
| Pack Type | Single-Use Vial |
| Route Of Administration | Subcutaneous / Intravenous |
| Therapeutic Category | Antineoplastic / Oncology Medicine |
| Composition | Azacitidine IP 100 Mg |
| Manufacturer | Medion Biotech Pvt. Ltd. |
| Storage Conditions | Store At 25°C; Excursions Permitted To 15°C–30°C |
| Business Type | Manufacturer, Exporter, Supplier |
| Strength | 200mg |
| Storage | As Directed On Pack |
| Dosage Form | Tablets |
| Manufacturer | Zydus Lifesciences Ltd. |
| Packaging Size | 14 Tablets |
| Packaging | 1 × 14 Tablets |
| Composition | Azacitidine 200mg |
| Usage | Acute Myeloid Leukemia (AML) |
| Active Ingredient | Azacitidine |
| Dosage | As Directed By Physician |
| Route | Oral |
| Therapeutic Class | Antineoplastic Agent |
| Administration | Oral Use |
| Prescription Status | Prescription Medicine |
| Business Type | Manufacturer, Exporter, Supplier |
| Administration | As Directed By Oncologist |
| Usage | Multiple Myeloma & Mantle Cell Lymphoma |
| Storage | Protect From Light & Moisture |
| Active Ingredient | Bortezomib |
| Strength | 2mg |
| Dosage Form | Lyophilized Injection |
| Pack Size | 1 Vial |
| Route | Intravenous / Subcutaneous |
| Reconstitution | 2ml 0.9% Sodium Chloride |
| Vial Type | Single-Use Vial |
| Prescription Status | Oncologist Prescription |
| Manufacturer | Samarth Life Sciences Pvt. Ltd. |
| Product Category | Oncology Medicine |
| Therapeutic Class | Proteasome Inhibitor |
| Business Type | Manufacturer, Exporter, Supplier |
| Strength | 2mg/Vial |
| Dosage Form | Lyophilized Powder |
| Storage | Below 25°C; Excursions Permitted Up To 30°C |
| Composition | Bortezomib IP |
| Route | Intravenous / Subcutaneous |
| Vial Type | Single Dose Vial |
| Iv Reconstitution | 2ml 0.9% Sodium Chloride |
| Iv Final Concentration | 1mg/ml |
| Sc Reconstitution | 0.8ml 0.9% Sodium Chloride |
| Sc Final Concentration | 2.5mg/ml |
| Therapeutic Class | Antineoplastic |
| Drug Class | Proteasome Inhibitor |
| Indication | Multiple Myeloma |
| Additional Indication | Mantle Cell Lymphoma |
| Light Protection | Protect From Light And Moisture |
| Manufacturer | Kwalty Pharmaceuticals Ltd. |
| Marketed By | Biomak Laboratories Pvt. Ltd. |
| Prescription | Schedule H Prescription Drug |
| Special Handling | Cytotoxic Agent |
| Business Type | Manufacturer, Exporter, Supplier |
| Strength | 2mg/Vial |
| Dosage Form | Lyophilized Injection |
| Form | Lyophilized Powder |
| Storage | Below 25°C |
| Brand | Borzomed 2mg |
| Composition | Bortezomib IP 2mg |
| Pack Size | 1 Vial |
| Route | Intravenous / Subcutaneous |
| Iv Reconstitution | 3.5ml 0.9% Sodium Chloride |
| Iv Final Concentration | 1mg/ml |
| Sc Reconstitution | 1.4ml 0.9% Sodium Chloride |
| Sc Final Concentration | 2.5mg/ml |
| Drug Class | Proteasome Inhibitor |
| Therapeutic Class | Antineoplastic |
| Indications | Multiple Myeloma, Mantle Cell Lymphoma |
| Vial Type | Single-Dose Vial |
| Temperature Excursion | Permitted Up To 30°C |
| Protection | Protect From Light And Moisture |
| Prescription | Oncologist Prescription Only |
| Manufacturer | Medicamen Biotech Ltd. |
10 Vial (MOQ)
| Business Type | Manufacturer, Exporter, Supplier |
| Form | Lyophilized Powder |
| Storage | Below 25°C |
| Brand | Borzomed 3.5mg |
| Strength | 3.5mg/Vial |
| Dosage Form | Lyophilized Injection |
| Administration | IV/SC Only |
| Composition | Bortezomib 3.5mg |
| Pack Size | 1 Vial |
| Route | Intravenous / Subcutaneous |
| Reconstitution Iv | 3.5ml 0.9% Sodium Chloride |
| Final Iv Concentration | 1mg/ml |
| Reconstitution Sc | 1.4ml 0.9% Sodium Chloride |
| Final Sc Concentration | 2.5mg/ml |
| Drug Class | Proteasome Inhibitor |
| Therapeutic Class | Antineoplastic |
| Indications | Multiple Myeloma, Mantle Cell Lymphoma |
| Vial Type | Single-Dose Vial |
| Temperature Excursion | Up To 30°C |
| Protection | Protect From Light And Moisture |
| Prescription | Cancer Specialist Prescription Only |
| Manufacturer | Medicamen Biotech Ltd. |
| Business Type | Manufacturer, Exporter, Supplier |
| Strength | 100mg/1ml |
| Dosage Form | Injection |
| Storage | Below 25°C |
| Composition | Cytarabine IP |
| Net Volume | 1ml |
| Route | IV Infusion |
| Vial Type | Single Dose Vial |
| Therapeutic Class | Antineoplastic |
| Drug Class | Antimetabolite |
| Indication | Blood Cancer Treatment |
| Light Protection | Protect From Light |
| Preservatives | No Antibacterial Preservatives |
| Packaging Type | Glass Vial In Carton |
| Manufacturer | Medion Biotech Pvt. Ltd. |
| Marketer | Medion Biotech Pvt. Ltd. |
| Prescription | Schedule G Prescription Drug |
| Business Type | Manufacturer, Exporter, Supplier |
| Active Ingredient | Eltrombopag Olamine |
| Strength | 50 Mg |
| Dosage Form | Tablet |
| Brand Name | Thropag |
| Packaging Size | 7 Tablets |
| Pack Configuration | 1 × 7 Tablets |
| Tablet Type | Film-Coated Tablet |
| Route Of Administration | Oral |
| Therapeutic Category | Hematology Medicine |
| Storage | Store Below 30°C |
| Storage Condition | Protect From Light & Moisture |
| Manufacturer | Medion Biotech Pvt. Ltd. |
| Business Type | Manufacturer, Exporter, Supplier |
| Active Ingredient | Eltrombopag |
| Composition | Eltrombopag Olamine Equivalent To Eltrombopag 50mg |
| Strength | 50mg |
| Dosage Form | Film-Coated Tablet |
| Packaging Size | 4 × 7 Tablets |
| Total Pack Quantity | 28 Tablets |
| Route Of Administration | Oral |
| Therapeutic Class | Blood Related |
| Drug Class | Thrombopoietin Receptor Agonist |
| Indications | Immune Thrombocytopenia, Hepatitis C-Associated Thrombocytopenia, Severe Aplastic Anemia |
| Tablet Color | White |
| Coloring Agent | Titanium Dioxide IP |
| Excipients | Q.S. |
| Storage | Below 30°C |
| Packaging Type | Blister Strips In Box |
| Form | Solid Film-Coated Tablets |
| Prescription Status | Prescription Required |
| Dosage | As Directed By Hematologist/Oncologist |
| Manufacturer | Medicamen Biotech Ltd. |
| Marketed By | Medicamen Biotech Ltd. |
| Brand Name | Eltropag 50mg |
10 Box (MOQ)
| Business Type | Manufacturer, Exporter, Supplier |
| Active Ingredient | Eltrombopag |
| Color | White/Off-White |
| Composition | Eltrombopag Olamine Equivalent To Eltrombopag 50mg |
| Strength | 50mg |
| Dosage Form | Film-Coated Tablets |
| Packaging Size | 4 × 7 Tablets |
| Total Quantity | 28 Tablets |
| Therapeutic Class | Blood Related |
| Drug Class | Thrombopoietin Receptor Agonist |
| Route Of Administration | Oral |
| Indications | Chronic ITP, Severe Aplastic Anemia, HCV-Associated Thrombocytopenia |
| Excipient | Q.s. |
| Coloring Agent | Titanium Dioxide IP |
| Storage | Store Below 30°C |
| Packaging Type | Blister Strips In Carton |
| Prescription | Hematologist/Oncologist Prescription Only |
| Manufacturer | Medicamen Biotech Ltd. |
| Brand Name | Eltropag 50mg |
| Business Type | Manufacturer, Exporter, Supplier |
| Manufacturer | Medion Biotech Pvt. Ltd. |
| Composition | Ibrutinib |
| Country of Origin | India |
| Strength | 140mg |
| Brand Name | Ibruon |
| Packaging Size | 30 Capsules |
| Packaging Type | Blister Pack |
| Storage | Do Not Store Above 30°C |
| Dosage Form | Hard Gelatin Capsules |
| Route Of Administration | Oral |
| Usage | As Directed By Oncologist |
| Therapeutic Class | Anticancer Medicine |
| Capsule Shell | Approved Colour Used |
| Prescription | Prescription Required |
| Product Status | Cytotoxic Agent |
| Administration | Swallow Whole |
| Marketed By | Medion Biotech Pvt. Ltd. |
10 Box (MOQ)
| Business Type | Manufacturer, Exporter, Supplier |
| Storage | Store In A Cool, Dry Place |
| Manufacturer | ZEE Laboratories Ltd. |
| Strength | 140 Mg |
| Packaging Size | 30 Capsules |
| Brand Name | Ibruzee 140 |
| Composition | Ibrutinib 140 Mg |
| Active Ingredient | Ibrutinib |
| Dosage Form | Hard Gelatin Capsules |
| Route Of Administration | Oral |
| Capsule Type | Hard Gelatin Capsule |
| Storage Temperature | Below 30°C |
| Light Protection | Protect From Light & Moisture |
| Business Type | Manufacturer, Exporter, Supplier |
| Strength | 100mg/1ml |
| Dosage Form | Injection |
| Storage | Below 30°C |
| Composition | Cytarabine BP |
| Packaging Size | 1ml |
| Route Of Administration | Intravenous / Subcutaneous |
| Vial Type | Single Dose Vial |
| Therapeutic Class | Antineoplastic |
| Drug Class | Antimetabolite |
| Indication | Leukemia Treatment |
| Light Protection | Protect From Light |
| Preservatives | None |
| Packaging Type | Glass Vial In Carton |
| Manufacturer | Admac Lifesciences Ltd. |
| Marketed By | Biomak Laboratories Pvt. Ltd. |
| Prescription | Schedule G Prescription Drug |
| Special Handling | Cytotoxic Agent |
| Business Type | Manufacturer, Exporter, Supplier |
| Strength | 100mg/Vial |
| Packaging | Glass Vial In Carton |
| Product Name | Makmustine Bendamustine 100mg Injection |
| Composition | Bendamustine Hydrochloride IP |
| Dosage Form | Lyophilized Injection |
| Route Of Administration | IV Infusion |
| Vial Type | Single Dose Vial |
| Reconstitution | 20ml Sterile Water For Injection |
| Further Dilution | 0.9% Sodium Chloride / 2.5% Dextrose Solution |
| Therapeutic Class | Antineoplastic |
| Drug Class | Alkylating Agent |
| Indication | Chronic Lymphocytic Leukemia |
| Additional Indication | Non-Hodgkin Lymphoma |
| Storage | Below 30°C |
| Light Protection | Protect From Light |
| Manufacturer | Biomak Laboratories Pvt. Ltd. |
| Prescription | Schedule H Prescription Drug |
| Special Handling | Cytotoxic Medicine |
| Business Type | Manufacturer, Exporter, Supplier |
| Composition | Eltrombopag Olamine |
| Strength | 50mg |
| Dosage Form | Film-Coated Tablets |
| Packaging Size | 4 × 7 Tablets |
| Total Quantity | 28 Tablets |
| Route Of Administration | Oral |
| Therapeutic Class | Hematopoietic Agent |
| Drug Class | Thrombopoietin Receptor Agonist |
| Indications | Immune Thrombocytopenia, Severe Aplastic Anemia & HCV-Associated Thrombocytopenia |
| Active Ingredient Equivalent | Eltrombopag 50mg |
| Tablet Colour | Yellow |
| Storage | Below 30°C |
| Storage Precaution | Protect From Light |
| Packaging Type | Box Of Blister Strips |
| Prescription Status | Schedule H |
| Manufacturer | Hetero Healthcare Limited |
| Brand Name | Rompag |
| Business Type | Manufacturer, Exporter, Supplier |
| Packaging Size | 28 Tablets |
| Usage | As Directed By Oncologist |
| Packaging Type | Blister Pack |
| Composition | Venetoclax |
| Storage | Store Below 30°C |
| Strength | 100mg |
| Prescription | Prescription Required |
| Dosage Form | Film-Coated Tablets |
| Manufacturer | Biotech |
| Brand Name | Valentax 100 |
| Product Name | Valentax Venetoclax 100mg Tablets |
| Route Of Administration | Oral |
| Therapeutic Class | Anticancer Medicine |
| Tablet Color | Yellow Oxide Of Iron & Titanium Dioxide |
| Storage Condition | Protect From Light & Moisture |
| Product Status | Cytotoxic Agent |
| Administration | As Directed By Oncologist |
| Safety | Keep Out Of Reach Of Children |
Raise your Query
Hi! Simply click below and type your query.
Our experts will reply you very soon.